Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung

Clinical trial NCT00503295 · COMPLETED

Trial details

NCT number: NCT00503295
Sponsor: Oncolytics Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Ewing Sarcoma Family Tumors Malignant Fibrous Histiocytoma Sarcoma, Synovial Fibrosarcoma Leiomyosarcoma

Start date: 2007-06-01
Primary completion: 2011-02-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.